Immediate Impact
24 standout
Citing Papers
Gene Editing for CEP290 -Associated Retinal Degeneration
2024 Standout
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Works of Francesca Parisi being referenced
Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy
2020
Microperimetric Biofeedback in AMD Patients
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Francesca Parisi | 68 | 49 | 67 | 75 | 72 | 49 | 475 | |
| Claudia M. Trujillo‐Vargas | 30 | 23 | 53 | 48 | 42 | 30 | 552 | |
| Wendy M. Townsend | 43 | 39 | 25 | 179 | 156 | 44 | 528 | |
| R. W. Diters | 160 | 84 | 29 | 46 | 84 | 30 | 535 | |
| Francisco J. Trigo‐Tavera | 60 | 37 | 16 | 25 | 46 | 40 | 428 | |
| L.Z. Saunders | 94 | 33 | 22 | 20 | 66 | 34 | 414 | |
| B. Knight | 28 | 61 | 44 | 77 | 32 | 27 | 444 | |
| Andrea Fuchs‐Baumgartinger | 220 | 119 | 36 | 32 | 25 | 44 | 470 | |
| James N. Shively | 39 | 40 | 12 | 55 | 43 | 38 | 487 | |
| Jacqueline W. Pearce | 63 | 39 | 12 | 49 | 133 | 26 | 430 | |
| Janver D. Krehbiel | 130 | 70 | 20 | 24 | 34 | 33 | 499 |
All Works
Login with ORCID to disown or claim papers
Loading papers...